Dermapharm Holding SE Common Stock

The latest common stock for DMP.DE is $50M as of September 2026. That compares with $54M in the prior-year period — down 8.2% year over year. Investors often review this figure alongside Dermapharm Holding SE's historical trend and sector peers before judging valuation or financial health.

Over the past year, DMP.DE's common stock moved from $54M to $50M — a 8.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Dermapharm Holding SE's operating scale or balance-sheet position.

A common stock figure of $50M for DMP.DE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting DMP.DE's common stock ($50M), review year-over-year change from $54M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.